SEC Form 3/A · accession 0000950142-18-000969
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owners
Andrew N Schiff
10% Owner
Steve Elms
10% Owner
Aisling Capital IV, LP
10% Owner
Aisling Capital Partners IV LLC
10% Owner
Aisling Capital Partners IV, LP
10% Owner
Period of report
Mar 29, 2018
Accepted (ET)
Apr 12, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value of $0.0001F1 | holding | — | — | — | 1,600,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are directly held by Aisling Capital IV, LP ("Aisling"), and may be deemed to be benefically owned by Aisling Capital Partners IV, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners IV LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the "Managers") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms.
Remarks
This amendment is being filed solely to add Aisling GP and Aisling Partners as reporting persons and correct the addresses for Mr. Elms and Dr. Schiff. There are no other changes being made by this amendment.